Delivery Order SPE2DB20D1004-SPE2DB23FF4H3

Award Date 3/14/23
Potential Completion Date 3/15/23
Potential Value $3.3K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $2,808.93 for the supply of 4563583486 TYPHIM VI 25 MCG/0.5 ML VIAL 10ML. The contract was issued by the Defense Logistics Agency (DLA), a major defense agency, and has a period of performance through February 8, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distribution company that has been awarded...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $25,106.82, is for the delivery of the pharmaceutical product TYPHIM VI 25 MCG/0.5 ML VIAL 10ML. It is a firm fixed-price delivery order with a completion date of May 3, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $74,904.80 for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product. The award was issued by the Defense Logistics Agency (DLA) on March 6, 2024, with a completion date of March 7, 2024. The contract has a Firm Fixed Price pricing type and does not include any set-aside designations, indicating open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccines to the Defense Logistics Agency (DLA). The $7,255.27 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of November 27, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award, valued at $11,235.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a delivery order for the provision of 4564926947 TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of June 18, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, holds a single-award Indefinite...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $4,722.50 from the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of various pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and other critical care items. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $3,249.18, is for the delivery of 4565123415 TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a pharmaceutical product. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,872.64 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product, with a completion date of February 22, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor and will deliver the product to the DLA Troop Support Medical facilities supporting the...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $37,452.40 for the supply of 4563971703 - TYPHIM VI 25 MCG/0.5 ML VIAL 10ML. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to provide pharmaceutical products and medical supplies to military treatment...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,044.96 issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract covers the provision of various pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas. Amerisourcebergen holds a significant Indefinite Delivery Contract...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB23FF4H3
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract is a Delivery Order worth $3,295.92 with a period of performance through March 15, 2023.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This contract award is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.

Generated 2/27/25, 11:56 AM